版本:
中国

BRIEF-Novartis' Zykadia wins FDA approval as initial therapy for type of lung cancer

May 26 Novartis Ag

* Novartis receives FDA approval for expanded use of zykadia® in first-line alk-positive metastatic non-small cell lung cancer (nsclc) Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐